Family-based analysis of susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3

Human Reproduction

Volumn 27, Issue 1, 2012, Pages 294-298

  Zhao, Han ^a,b,c   Xu, Xinghua ^a,b,c   Xing, Xiuye ^a,b,c   Wang, Jianfeng ^a,b,c   He, Lin ^d,e,f   Shi, Yongyong ^f   Shi, Yuhua ^a,b,c   Zhao, Yueran ^a,b,c   Chen, Zi Jiang ^a,b,c  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Shandong Provincial Key Laboratory of Reproductive Medicine   (China)

^d FUDAN UNIVERSITY   (China)

^e Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^f SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

genome wide association study; polycystic ovary syndrome; single nucleotide polymorphism; transmission disequilibrium test

Indexed keywords

GLUCOSE; INSULIN; TESTOSTERONE;

ADULT; ALLELE; ARTICLE; CHINESE; CHROMOSOME 2P; CHROMOSOME 9Q; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PEDIGREE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TESTOSTERONE BLOOD LEVEL; VALIDATION PROCESS;

EID: 83755185526     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der379     Document Type: Article

References (25)

1. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265. (Pubitemid 40202029)
2. Carmina E. Cardiovascular risk and events in polycystic ovary syndrome. Climacteric 2009;12(Suppl 1):22-25.
3. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y, Li Z, You L, Zhao J, Liu J et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 2011;43:55-59.
4. Del Villar K, Miller CA. Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons. Proc Natl Acad Sci USA 2004;101:4210-4215. (Pubitemid 38405908)
5. Drieschner N, Belge G, Rippe V, Meiboom M, Loeschke S, Bullerdiek J. Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin. Thyroid 2006;16:1091-1096. (Pubitemid 44864483)
6. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352:1223-1236.
7. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141-146. (Pubitemid 29028311)
8. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-1447.
9. Franks S, Gharani N, McCarthy M. Genetics and infertility II: candidate genes in polycystic ovary syndrome. Hum Reprod Update 2001; 7:405-410. (Pubitemid 32655326)
10. Goodarzi MO, Azziz R. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Prac Res Clin Endocrinol Metab 2006; 20:193-200.
11. Hu C, Zhang R, Wang C, Wang J, Ma X, Lu J, Qin W, Hou X, Wang C, Bao Y et al. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. PLoS One 2009;4:e7643.
12. Kahsar-Miller MD, Nixon C, Boots LR, Go RC, Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 2001;75:53-58. (Pubitemid 32042114)
13. Kandaraki E, Christakou C, Diamanti-Kandarakis E. Metabolic syndrome and polycystic ovary syndrome . . . and vice versa. Arq Bras Endocrinol Metabol 2009;53:227-237.
14. Legro RS, Driscoll D, Strauss JF III, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 1998;95:14956-14960. (Pubitemid 29003738)
15. Menke MN, Strauss JF III. Genetic approaches to polycystic ovarian syndrome. Curr Opin Obstet Gynecol 2007;19:355-359. (Pubitemid 47067099)
16. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81:19-25.
17. Sanghera DK, Been L, Ortega L, Wander GS, Mehra NK, Aston CE, Mulvihill JJ, Ralhan S. Testing the association of novel meta-analysis-derived diabetes risk genes with type II diabetes and related metabolic traits in Asian Indian Sikhs. J Hum Genet 2009; 54:162-168.
18. Shi Y, Gao X, Sun X, Zhang P, Chen Z. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women. Fertil Steril 2008; 90:1139-1143.
19. Stancáková A, Kuulasmaa T, Paananen J, Jackson AU, Bonnycastle LL, Collins FS, Boehnke M, Kuusisto J, Laakso M. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Diabetes 2009;58:2129-2136.
20. Urbanek M. The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 2007;3:103-111. (Pubitemid 46146963)
21. Urbanek M, Spielman RS. Genetic analysis of candidate genes for the polycystic ovary syndrome. Curr Opin Endocrinol Diabetes 2002; 9:492-501. (Pubitemid 36735168)
22. Vink J, Sadrzadeh SM, Lambalk CB, Boomsma DI. Heritability of polycystic ovary syndrome (PCOS) in a Dutch twin-family study. J Clin Endocrinol Metab 2006;91:2100-2104. (Pubitemid 43854989)
23. Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil(Camb) 2000;3:101-105.
24. Xu X, Zhao H, Shi Y, You L, Bian Y, Zhao Y, Chen ZJ. Family association study between INSR gene polymorphisms and PCOS in Han Chinese. Reprod Biol Endocrinol 2011;9:76.
25. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, de Bakker PI, Abecasis GR, Almgren P, Andersen G et al. Meta-analysis of genomewide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008;40:638-45. (Pubitemid 351601209)